MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Repligen Corp

Suletud

SektorTervishoid

130.71 1.76

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

124.79

Max

132.77

Põhinäitajad

By Trading Economics

Sissetulek

-33M

-34M

Müük

13M

168M

P/E

Sektori keskmine

466.89

63.778

Aktsiakasum

0.44

Kasumimarginaal

-20.215

Töötajad

1,778

EBITDA

12M

34M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+47.29% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-1.8B

7.5B

Eelmine avamishind

128.95

Eelmine sulgemishind

130.71

Uudiste sentiment

By Acuity

26%

74%

73 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Repligen Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. apr 2025, 23:55 UTC

Kuumad aktsiad

Stocks to Watch: RH, Nike, Dollar Tree, Apple

2. apr 2025, 22:50 UTC

Suurimad hinnamuutused turgudel

E.l.f. Beauty, Estee Lauder, Coty Shares Fall on Reciprocal Tariffs Hit

2. apr 2025, 21:08 UTC

Tulu

RH 4Q Revenue Misses Guidance, Looks to Offset Reciprocal Tariffs -- Update

2. apr 2025, 21:00 UTC

Tulu

RH 4Q Revenue Misses Guidance, Looks to Offset Reciprocal Tariffs

2. apr 2025, 23:56 UTC

Market Talk

Gold Rises as Trump's Tariffs Enhance Safe-Haven Appeal -- Market Talk

2. apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

2. apr 2025, 23:44 UTC

Market Talk

Nikkei Likely to Fall After U.S. Tariff Plan -- Market Talk

2. apr 2025, 23:44 UTC

Peamised uudised

Some GOP Senators Break With Trump to Reject Canada Tariffs -- WSJ

2. apr 2025, 23:32 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 23:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. apr 2025, 23:32 UTC

Market Talk

Trump's Tariffs on Australia Conspicuously Unfriendly -- Market Talk

2. apr 2025, 23:12 UTC

Market Talk

Global Equities Roundup: Market Talk

2. apr 2025, 23:12 UTC

Market Talk

Trump Tariff 'Blow Bigger Than We Expected,' Capital Economics Says -- Market Talk

2. apr 2025, 23:10 UTC

Market Talk

Canada, Mexico Get Short-Term Advantage From Trump's Tariff Moves -- Market Talk

2. apr 2025, 23:09 UTC

Market Talk

U.S. Effective Tariff Rate Highest in 131 Years -- Market Talk

2. apr 2025, 23:09 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 22:57 UTC

Market Talk

Australia Spared Worst Of US Tariff Hikes -- Market Talk

2. apr 2025, 22:56 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 22:56 UTC

Market Talk

US Equity Futures Down as Tariff Hikes Stoke Recession Fears -- Market Talk

2. apr 2025, 22:43 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

AppLovin, Amazon Emerge as TikTok Bidders Ahead of Trump's Deadline, Sources Say -- 2nd Update

2. apr 2025, 22:12 UTC

Market Talk

Trump's Tariff Order May Set Path for New U.S.-Canada Pact -- Market Talk

2. apr 2025, 21:48 UTC

Peamised uudised

The Stock Market Pain Is Just Getting Started. 'This is How You Sabotage the World's Economic Engine.' -- Barrons.com

2. apr 2025, 21:41 UTC

Market Talk

USD Reaction To Trump's Tariffs Limited So far -- Market Talk

2. apr 2025, 21:17 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

2. apr 2025, 21:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. apr 2025, 21:17 UTC

Market Talk

Mexican Peso Gains as Worst Tariff Fears Avoided -- Market Talk

2. apr 2025, 21:04 UTC

Peamised uudised

Trump's Tariffs Could Blow Up Big Pharma's Tax Shelter -- Heard on the Street -- Update

2. apr 2025, 21:03 UTC

Market Talk

Treasury Yields, Dollar, Stock Futures Fall as Markets Digest Tariffs -- Market Talk

2. apr 2025, 20:53 UTC

Tulu

Kaiser Aluminum Changes Method From Last-In, First-Out to Weighted Avg Cost Effective Jan. 1, 2025

2. apr 2025, 20:52 UTC

Tulu

Kaiser Aluminum Changes Inventory Acctg Methodology

Võrdlus sarnastega

Hinnamuutus

Repligen Corp Prognoos

Hinnasiht

By TipRanks

47.29% tõus

12 kuu keskmine prognoos

Keskmine 189.27 USD  47.29%

Kõrge 220 USD

Madal 155 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Repligen Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

10

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

125.39 / 137.12Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

73 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.